NFKB1 and bladder transitional cell carcinoma: Our study confirmed that PI16 exerted its inhibitory role in the malignant progression and metastasis of BLCA by inhibiting NF-κB activation, which may provide new clues for the understanding of tumours associated with abnormal NF-κB activation, and targeting PI16 may achieve control of abnormal NF-κB activation in tumours.